ARDUINI, Arduino
 Distribuzione geografica
Continente #
NA - Nord America 1.693
AS - Asia 971
EU - Europa 968
Continente sconosciuto - Info sul continente non disponibili 187
SA - Sud America 98
AF - Africa 19
OC - Oceania 3
Totale 3.939
Nazione #
US - Stati Uniti d'America 1.631
SG - Singapore 356
CN - Cina 287
IT - Italia 163
UA - Ucraina 142
SE - Svezia 120
IE - Irlanda 118
TR - Turchia 108
GB - Regno Unito 98
RU - Federazione Russa 92
FR - Francia 89
VN - Vietnam 83
BR - Brasile 77
DE - Germania 64
IN - India 64
FI - Finlandia 33
CA - Canada 22
BD - Bangladesh 13
HK - Hong Kong 13
PL - Polonia 13
ZA - Sudafrica 9
CO - Colombia 7
ES - Italia 7
HN - Honduras 7
IQ - Iraq 7
JP - Giappone 7
MX - Messico 7
AT - Austria 6
IL - Israele 6
NL - Olanda 6
EC - Ecuador 5
KR - Corea 5
BE - Belgio 4
CR - Costa Rica 4
ID - Indonesia 4
PR - Porto Rico 4
AR - Argentina 3
CZ - Repubblica Ceca 3
GR - Grecia 3
JM - Giamaica 3
KE - Kenya 3
NI - Nicaragua 3
SA - Arabia Saudita 3
SV - El Salvador 3
UZ - Uzbekistan 3
AU - Australia 2
CL - Cile 2
EE - Estonia 2
GT - Guatemala 2
MA - Marocco 2
OM - Oman 2
PH - Filippine 2
PK - Pakistan 2
SC - Seychelles 2
TT - Trinidad e Tobago 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AW - Aruba 1
BB - Barbados 1
BG - Bulgaria 1
CG - Congo 1
CH - Svizzera 1
EG - Egitto 1
EU - Europa 1
GD - Grenada 1
GP - Guadalupe 1
KZ - Kazakistan 1
LT - Lituania 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PA - Panama 1
PE - Perù 1
PS - Palestinian Territory 1
PT - Portogallo 1
PY - Paraguay 1
QA - Qatar 1
RO - Romania 1
SN - Senegal 1
UY - Uruguay 1
VE - Venezuela 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 3.754
Città #
Singapore 234
San Jose 186
Chandler 177
Jacksonville 151
Ashburn 126
Dublin 118
Beijing 85
Southend 68
Izmir 67
Council Bluffs 65
New York 62
Princeton 61
Nanjing 48
Dallas 45
Los Angeles 40
Wilmington 32
Ho Chi Minh City 31
Cambridge 26
Santa Clara 26
Chieti 25
Dearborn 22
Nanchang 21
Tongling 17
Altamura 16
Boardman 16
North Bergen 15
Ann Arbor 14
Buffalo 14
Woodbridge 14
São Paulo 13
Dong Ket 11
Orem 11
Hong Kong 10
Phoenix 10
Helsinki 9
Moscow 9
Shenyang 9
Vittuone 9
Washington 9
Columbus 8
Hanoi 8
Houston 8
Milan 8
The Dalles 8
Atlanta 7
Brooklyn 7
Hefei 7
Jinan 7
Johannesburg 7
Nuremberg 7
Warsaw 7
Chicago 6
Frankfurt am Main 6
Hebei 6
London 6
Naples 6
Ningbo 6
Stockholm 6
Tianjin 6
Jiaxing 5
Kunming 5
Manchester 5
Montreal 5
Philadelphia 5
Redondo Beach 5
Rome 5
San Pedro Sula 5
Seoul 5
Tokyo 5
Wroclaw 5
Bangalore 4
Brasília 4
Buccinasco 4
Changsha 4
Da Nang 4
Denver 4
Falls Church 4
Irving 4
Kimball 4
Munich 4
Norwalk 4
Ottawa 4
Pescara 4
Richmond 4
San José 4
Silver Spring 4
Albany 3
Augusta 3
Bogotá 3
Boston 3
Brno 3
Brussels 3
Carolina 3
Charlotte 3
Chennai 3
Hangzhou 3
Kingston 3
La Mesa 3
Leawood 3
Managua 3
Totale 2.220
Nome #
Effects of dichloroacetate as single agent or in combination with GW6471 and metformin in paraganglioma cells 210
Effect of an L-carnitine-containing peritoneal dialysate on insulin sensitivity in patients treated with CAPD: a 4-month, prospective, multicenter randomized trial. 206
L-carnitine inhibits a subset of platelet activation responses in chronic uraemia 170
L-Carnitine is an osmotic agent suitable for peritoneal dialysis 162
Current opinion on usage of L-carnitine in end-stage renal disease patients on peritoneal dialysis 156
In vitro microbiology studies on a new peritoneal dialysis connector 155
Carnitine in metabolic disease: potential for pharmacological intervention 153
Carnitine palmitoyltransferase and acyl-coA binding protein: two more players in the membrane phospholipid fatty acid turnover of human red cells? 150
Cellular properties of human erythrocytes preserved in saline-adenine-glucose-mannitol in the presence of L-carnitine 150
Effect of ischemia and reperfusion on antioxidant enzymes and mitochondrial inner membrane proteins in perfused rat heart. 144
Change in plasma amino acid concentrations during breath-hold diving at high altitude. 143
Carnitine palmitoyltransferase as a potential target for treating diabetes: is inhibition or activation preferable? 142
Defining the potential antidepressant mode of action of acetyl-l-carnitine. 139
Vitamin E induction of experimental allergic encephalomyelitis in the Lewis rat. 138
Effects of L-carnitine administration on erythrocyte survival in haemodialysis patients 134
L-carnitine in uremic anemia 126
Hypercoagulability in uraemia: role of increased surface exposure of phosphatidylserine on erythrocytes 113
Red blood cells may contribute to hypercoagulability in uraemia via enhanced surface exposure of phosphatidylserine 112
Coupling Osmotic Efficacy with Biocompatibility in Peritoneal Dialysis: A Stiff Challenge 110
The osmo-metabolic approach: a novel and tantalizing glucose-sparing strategy in peritoneal dialysis 106
Utilità di uno screening urinario in età scolastica 100
L-carnitine may decrease platelet activation response with phosphatidylserine exposure in chronic uraemia 96
null 96
Prevention of peritoneal sclerosis: a new proposal to substitute glucose with carnitine dialysis solution (biocompatibility testing in vitro and in rabbits) 93
La carnitina come agente osmo-metabolico nelle soluzioni di dialisi peritoneale 92
How to improve the biocompatibility of peritoneal dialysis solutions (without Jeopardizing the patient’s health) 92
Nuova proposta di sostituire il glucosio con la carnitina nelle soluzioni di dialisi peritoneale 89
Alterazioni eritrocitarie e loro possibile ruolo nelle complicanze cardiovascolari dell’uremia 81
null 79
Erythrocyte alterations and increased cardiovascular risk in chronic renal failure 64
null 55
Toward personalized haemodialysis by low molecular weight amino-containing compounds: future perspective of patient metabolic fungerprint 47
Carnitine acetyltransferase (CrAT) involvement in TGF-β1-induced keratocyte transdifferentiation and corneal fibrosis in vitro. 14
Sweeteners: erythritol, xylitol and cardiovascular risk—friend or foe? 14
PolyCore, a bimodal peritoneal dialysis solution based on xylitol, L-carnitine, and icodextrin: In vitro evidence of the peritoneal membrane protection, rationale, and design of the phase II pilot study EXCITE 8
Totale 3.939
Categoria #
all - tutte 15.905
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.905


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202298 0 0 0 0 9 3 7 7 17 6 8 41
2022/2023450 43 63 22 50 49 88 23 21 68 2 14 7
2023/2024237 13 5 17 5 17 116 30 1 1 9 2 21
2024/2025454 18 64 56 27 13 11 11 15 90 11 45 93
2025/20261.099 105 32 85 136 149 69 168 54 103 107 55 36
2026/2027367 27 50 72 149 69 0 0 0 0 0 0 0
Totale 3.939